MedPath

Vitamin C to Reduce Vasopressor Dose in Septic Shock

Phase 3
Withdrawn
Conditions
Septic Shock
Sepsis
Interventions
Drug: Placebos
Registration Number
NCT03835286
Lead Sponsor
Hospital Español de Mexico
Brief Summary

Randomized, controlled, double blind clinical trial. Adult patients admitted to the ICU of the Hospital Español de México with a diagnosis of septic shock will be included.

Patients will be randomized to one of the study groups:

Intervention Group: Vitamin C 6 grams in 250 ml of 0.9% saline solution every 24 hours, in continuous infusion for 72 hours.

Placebo Group: 0.9% saline solution 250 ml every 24 hours, in continuous infusion for 72 hours.

Detailed Description

Randomized, controlled, double blind clinical trial. Adult patients admitted to the ICU of the Hospital Español de México with a diagnosis of septic shock will be included.

Patients will be randomized to one of the study groups:

Intervention Group: Vitamin C 6 grams in 250 ml of 0.9% saline solution every 24 hours, in continuous infusion for 72 hours.

Placebo Group: 0.9% saline solution 250 ml every 24 hours, in continuous infusion for 72 hours.

Bottles will be identical, only identified by the sequential number of the patient that has been included.

Primary objective is to demonstrate that the administration of intravenous Vitamin C decreases the dose of exogenous vasopressors in patients with septic shock

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Adults
  • Septic Shock
Exclusion Criteria
  • Previous treatment exceeded 24 hours
  • Refusal to participate
  • Do Not Resuscitate
  • Participation in another trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vitamin CVitamin CVitamin C experimental group
ControlPlacebosPlacebos Controlled group
Primary Outcome Measures
NameTimeMethod
Vasopressor dose72 hours

Hourly dose of exogenous vasopressor

Secondary Outcome Measures
NameTimeMethod
Hours of vasopressor usethrough study completion, an average of 30 days

Total hours of vasopressor use

Days of mechanical ventilationthrough study completion, an average of 30 days

Total days of mechanical ventilation use

Days of Intensive Care Unit staythrough study completion, an average of 30 days

Total days of intensive care unit stay

Mortality in Intensive Care Unitthrough study completion, an average of 30 days

Rate of intensive care mortality

Trial Locations

Locations (1)

Hospital Español

🇲🇽

Mexico City, Mexico

© Copyright 2025. All Rights Reserved by MedPath